(N-(CYANOMETHYL)-4-(2-(4-Morpholinophenylamino)PYRIMIDIN-4-YL)BENZAMIDE
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 14/736,690, filed Jun 11, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,809,559 | (N-(CYANOMETHYL)-4-(2-(4-Morpholinophenylamino)PYRIMIDIN-4-YL)BENZAMIDE In force · Medium confidence | GlaxoSmithKline LLC | In force | Medium confidence | ||
| US RE48,285 | N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-YL) Benzamide In force · Low confidence | GlaxoSmithKline LLC | In force | Low confidence | ||
| US RE49,445 | N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-YL) Benzamide In force · Low confidence | GlaxoSmithKline LLC | In force | Low confidence | ||
| US RE50,497 | (N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-y l)Benzamide In force · Low confidence | GlaxoSmithKline LLC | In force | Low confidence | ||
| US 9,469,613 | (N-(CYANOMETHYL)-4-(2-(4-Morpholinophenylamino)PYRIMIDIN-4-YL)BENZAMIDE Surrendered on reissue Oct 27, 2020 Surrendered on reissue Oct 27, 2020 · High confidence | GlaxoSmithKline LLC | Surrendered on reissue Oct 27, 2020 | Surrendered on reissue Oct 27, 2020 | High confidence | |
| Application 19/245,507 | (N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-y l)Benzamide Pending Not granted | GlaxoSmithKline LLC | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.